N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits.
about
How a Plant Lectin Recognizes High Mannose OligosaccharidesN-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay.HAE therapies: past present and future.Analysis and validation of carbohydrate three-dimensional structures.Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milkUse of transgenic animals in biotechnology: prospects and problems.Recombinant and plasma-purified human c1 inhibitor for the treatment of hereditary angioedema.N-/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbitsPopulation pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedemarhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.Conestat alfa for the treatment of angioedema attacks.Target levels of functional C1-inhibitor in hereditary angioedema.Recombinant human c1 inhibitor (conestat alfa): in the treatment of angioedema attacks in hereditary angioedema.The Story of Angioedema: from Quincke to Bradykinin.Expression systems and species used for transgenic animal bioreactors.Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitor.Expression of Active Fluorophore Proteins in the Milk of Transgenic Pigs Bypassing the Secretory Pathway.Transient Expression of Functional Glucocerebrosidase for Treatment of Gaucher's Disease in the Goat Mammary Gland.Rabbit milk protein genes: from mRNA identification to chromatin structure.Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle.Biochemical characterization of LR769, a new recombinant factor VIIa bypassing agent produced in the milk of transgenic rabbits.Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.N- and O-glycosylation analysis of human C1-inhibitor reveals extensive mucin-type O-glycosylation.Highly sensitive glycosylamine labelling of O-glycans using non-reductive β-elimination.The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.Efficient production of human interferon beta in the white of eggs from ovalbumin gene-targeted hens.Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgeryNew promise and hope for treating hereditary angioedema
P2860
Q27645423-FAAEE5D4-1F75-4E45-B514-D4B673691E5FQ33273194-B43400A9-6427-478C-B20E-B50D6B3B75E0Q33848413-CD323AF1-F1ED-4434-90D2-638BEC60CD6FQ34063768-4272C1AC-C4A4-44FA-8964-602A014A2D2AQ34930770-CE0BB5D0-1202-4922-B356-3B42CCF811FDQ35835707-A6E9303D-AD71-4FF0-ACCA-0A6FF64F1942Q36730328-C1865924-E6E2-4FF7-A98E-FF8E4733F78DQ36882540-598CF453-571B-4F2F-9196-37C04CB8C525Q37277251-02B7BE0B-2D7A-4CDD-A331-155C3C77E68EQ37353438-BD8B69E1-4BC4-4911-AD03-74992E6BF508Q37855944-558C9FC8-1679-46B3-BC5F-47971A83F558Q37900837-55BB1338-2EF2-4BD1-BE2D-677B8C964622Q37933448-53057DE4-23BB-406D-A17A-51AE4AE56629Q38040455-E9B8E738-6F96-46BB-8D71-B115F9ED2F47Q38855032-6FF4C89A-9991-4477-8DE9-CE267A712880Q39468670-C8FE3D9E-3055-4757-BFC2-562CF8662583Q40031791-356FCE00-D808-41C1-B22E-C3E83080D797Q40271068-E4121D2E-BD3F-4F20-A309-E4BD50135375Q41109224-272E4E39-A0EF-426A-83D0-33ED46CFE5F6Q42719784-CDEE2197-1A6C-42F0-96D2-BABC929B4078Q43569961-D45BEDB0-D2BD-45E5-B689-D08D993D898FQ45868639-E8B16337-CE12-4C14-B1FF-9929D02A1677Q45935551-8EBFF8D0-7254-4BD4-BFB7-E4D5BF1A98C3Q49886884-878C425B-EB13-4DAB-B5D6-69EA14E6163CQ51188868-260675E2-7341-4F92-9C70-F2EACD4065DDQ55106013-7D74B378-51BC-429E-9BBA-A26FBA920F10Q55613157-F4B73C85-46E8-4C0A-B15D-B9EF8913E156Q56031831-624A111E-6919-4CD9-9A03-454E45BAA99EQ58615572-895A3916-52A1-43E7-BD11-2ABA303BB9B3
P2860
N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@ast
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@en
type
label
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@ast
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@en
prefLabel
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@ast
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@en
P2093
P356
P1433
P1476
N- and O-glycans of recombinan ...... he milk of transgenic rabbits.
@en
P2093
Frank R Pieper
Jan H Nuijens
Johannes F G Vliegenthart
Johannis P Kamerling
Kate Koles
Maurice L M Mannesse
Patrick H C van Berkel
P356
10.1093/GLYCOB/CWH010
P577
2003-09-26T00:00:00Z